文献速递肾癌与肾肿瘤

与更长端粒长度相关的遗传变异与肾细胞癌风险增加相关

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
PubMed 文献 · Eur Urol · 2017-08-07

本研究采用孟德尔随机化方法,汇总6项全基因组关联研究中10784例肾细胞癌病例和20406例无癌对照的9个端粒长度相关变异,构建加权遗传风险评分。结果显示遗传推断的端粒长度越长,肾细胞癌风险越高(每预测增加1千碱基OR=2.07,95%CI 1.70-2.53)。

要点

  • 遗传推断的端粒长度每增加1千碱基,肾细胞癌风险OR=2.07(95%CI 1.70-2.53)。
  • 排除两个与肾细胞癌风险变异存在连锁不平衡的端粒变异后,关联仍显著(OR=1.73)。
  • 透明细胞癌、乳头状癌和嫌色细胞癌的探索性分析关联方向一致。

核心结论

  • 研究补充了越来越多证据,表明更长端粒长度的某些方面对肾细胞癌风险具有重要性。
  • 遗传推断的更长端粒长度与肾细胞癌风险增加相关。

研究设计与样本

  • 采用孟德尔随机化分析,汇总6项肾细胞癌全基因组关联研究(GWAS)中10784例病例和20406例无癌对照的基因型。
  • 将9个端粒长度相关变异聚合为预测白细胞端粒长度的加权遗传风险评分(GRS)。

主要发现

  • 遗传推断的更长端粒长度与肾细胞癌风险增加相关(每预测增加1千碱基OR=2.07,95%CI 1.70-2.53,p<0.0001)。
  • 排除两个与GWAS识别的肾细胞癌风险变异(rs10936599和rs9420907)存在连锁不平衡(R2>0.5)的端粒长度变异后,GRS与肾细胞癌风险的关联仍具有统计学显著性(OR=1.73,95%CI 1.36-2.21,p<0.0001)。
  • 探索性分析提示透明细胞癌(N=5573,OR=1.93,95%CI 1.50-2.49,p<0.0001)、乳头状癌(N=573,OR=1.96,95%CI 1.01-3.81,p=0.046)和嫌色细胞癌(N=203,OR=2.37,95%CI 0.78-7.17,p=0.13)与端粒长度GRS的关联具有可比性。

局限性

  • 嫌色细胞癌探索性分析的95%CI为0.78-7.17,未达统计学显著(p=0.13)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Relative telomere length in peripheral blood leukocytes has been evaluated as a potential biomarker for renal cell carcinoma (RCC) risk in several studies, with conflicting findings. OBJECTIVE: We performed an analysis of genetic variants associated with leukocyte telomere length to assess the relationship between telomere length and RCC risk using Mendelian randomization, an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations. DESIGN, SETTING, AND PARTICIPANTS: Genotypes from nine telomere length-associated variants for 10 784 cases and 20 406 cancer-free controls from six genome-wide association studies (GWAS) of RCC were aggregated into a weighted genetic risk score (GRS) predictive of leukocyte telomere length. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Odds ratios (ORs) relating the GRS and RCC risk were computed in individual GWAS datasets and combined by meta-analysis. RESULTS AND LIMITATIONS: Longer genetically inferred telomere length was associated with an increased risk of RCC (OR=2.07 per predicted kilobase increase, 95% confidence interval [CI]:=1.70-2.53, p<0.0001). As a sensitivity analysis, we excluded two telomere length variants in linkage disequilibrium (R2>0.5) with GWAS-identified RCC risk variants (rs10936599 and rs9420907) from the telomere length GRS; despite this exclusion, a statistically significant association between the GRS and RCC risk persisted (OR=1.73, 95% CI=1.36-2.21, p<0.0001). Exploratory analyses for individual histologic subtypes suggested comparable associations with the telomere length GRS for clear cell (N=5573, OR=1.93, 95% CI=1.50-2.49, p<0.0001), papillary (N=573, OR=1.96, 95% CI=1.01-3.81, p=0.046), and chromophobe RCC (N=203, OR=2.37, 95% CI=0.78-7.17, p=0.13). CONCLUSIONS: Our investigation adds to the growing body of evidence indicating some aspect of longer telomere length is important for RCC risk. PATIENT SUMMARY: Telomeres are segments of DNA at chromosome ends that maintain chromosomal stability. Our study investigated the relationship between genetic variants associated with telomere length and renal cell carcinoma risk. We found evidence suggesting individuals with inherited predisposition to longer telomere length are at increased risk of developing renal cell carcinoma.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Machiela MJ, Hofmann JN, Carreras-Torres R, et al. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. Eur Urol. 2017. PMID: 28797570. doi:10.1016/j.eururo.2017.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。